Microbial-Derived Daidzin (Eco-3) Suppresses RANKL-Induced Osteoclastogenesis by Targeting the TBK1–NFATc1 Signaling Axis
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177881 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nivethasri Lakshmana Perumal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, College of Medicine, Keimyung University, 1095 Dalgubeoldaero, Dalseo-gu, Daegu 42601, Republic of Korea. Hauptthemen laut MEDLINE: RANK Ligand, Osteoclasts, Signal Transduction, NFATC Transcription Factors. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ecowin Co., Ltd., 18, Techno jungang-daero 2-gil, Yuga-eup, Dalseong-gun, Ecowin Co., Ltd..
Abstract (Originalsprache)
Eco-3, a microbial-derived daidzin, has been reported to possess diverse biological activities; however, its effects on osteoclast differentiation and the underlying molecular mechanisms remain unclear. In the present study, we investigated the effects of Eco-3 on receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis and explored the signaling pathways involved using RAW264.7 macrophages. Eco-3 suppressed RANKL-induced osteoclast formation at the concentrations tested without significantly affecting cell viability. Eco-3 also altered F-actin organization and reduced the expression of key osteoclastogenic markers, including tartrate-resistant acid phosphatase (TRAP), nuclear factor of activated T cells c1 (NFATc1), c-Fos, and cathepsin K (CTSK). In particular, Eco-3 attenuated NFATc1 expression during the early stage of osteoclast differentiation, suggesting interference with the transcriptional program associated with osteoclastogenesis. Furthermore, RANKL stimulation progressively increased TANK-binding kinase 1 (TBK1) phosphorylation during osteoclast differentiation, whereas Eco-3 attenuated this activation. Genetic silencing of TBK1 suppressed osteoclast formation, while pharmacological inhibition of TBK1 reduced TBK1 phosphorylation, osteoclastogenic gene expression, and osteoclast formation. Collectively, these findings suggest that Eco-3 suppresses RANKL-induced osteoclastogenesis, at least in part, through modulation of the TBK1–NFATc1 signaling axis in RAW264.7 macrophages. Our findings identify TBK1 as a potential regulatory component of osteoclast differentiation and suggest that Eco-3 warrants further investigation as a potential bioactive candidate for osteoclast-related bone disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, College of Medicine, Keimyung University, 1095 Dalgubeoldaero, Dalseo-gu, Daegu 42601, Republic of Korea.
- Ecowin Co., Ltd., 18, Techno jungang-daero 2-gil, Yuga-eup, Dalseong-gun, Daegu 42415, Republic of Korea.
- Department of Rehabilitation Medicine, Daegu Catholic University School of Medicine, Nam-Gu, Daegu 42472, Republic of Korea.
ORCID-Profile: Gi-Young Park
Förderung
- Ecowin Co., Ltd., 18, Techno jungang-daero 2-gil, Yuga-eup, Dalseong-gun
- Ecowin Co., Ltd.
Zitieren
APA
Perumal, N. L., Koo, K. B., Park, G. Y., & Jang, B. C. (2026). Microbial-Derived Daidzin (Eco-3) Suppresses RANKL-Induced Osteoclastogenesis by Targeting the TBK1–NFATc1 Signaling Axis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177881
Vancouver
Perumal NL, Koo KB, Park GY, Jang BC. Microbial-Derived Daidzin (Eco-3) Suppresses RANKL-Induced Osteoclastogenesis by Targeting the TBK1–NFATc1 Signaling Axis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177881
BibTeX
@article{Perumal2026,
author = {Perumal, Nivethasri Lakshmana and Koo, Kyung-Bon and Park, Gi-Young and Jang, Byeong-Churl},
title = {Microbial-Derived Daidzin (Eco-3) Suppresses RANKL-Induced Osteoclastogenesis by Targeting the TBK1–NFATc1 Signaling Axis},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177881}
}
EUVIMED